Sexual Health Market
- 2026 年市場規模
- USD 45.67 Bn
- 2033 年預估規模
- USD 82.94 Bn
- 年複合成長率 CAGR
- 8.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Sexual Health Market, By Product Type (Erectile Dysfunction Drugs, Gender Dysphoria Drugs, Hypoactive Sexual Desire Disorder Drugs, Premature Ejaculation Drugs, Others), By Gender (Male, Female), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Sexual health is an important part of a person’s physical and mental health. Sexual health leads to the healthy sexual life without any sexual dysfunctions, and preventive measures to avoid sexually transmitted infections. The adult population largely suffers from one or more sexual disorders such as dyspareunia, erectile dysfunctions, hypoactive sexual desire disorder, premature (early) ejaculation, and others. According to National Center for Biotechnology Information 2016, sexual dysfunction is highly prevalent, and affects around 43% of women and 31% of men, globally. Currently, various treatment options such as medication, mechanical aids, sexual therapies, and others are available for treating such sexual dysfunctions and to improve sexual health of the person.
Market Dynamics
Increasing incidence and prevalence of sexual disorders is a major factor augmenting growth of the market. Some of the major factors which cause sexual dysfunction are aging population, stressful and unhealthy lifestyle, and other psychological parameters. According to a study published in the National Center for Biotechnology Information in April 2016, hypoactive sexual desire disorder (HSDD) is present in around 8.9% and 12.3% women in the age group of 18 - 44 years and 45 – 64 years, respectively.
Moreover, robust product development activities by major key players is engaged in the introduction of innovative and highly effective drug treatment for improving sexual health. For instance, in June 2019, AMAG Pharmaceuticals received the U.S. FDA approval for Vyleesi (bremelanotide) for treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Thus, increasing approvals by regulatory authorities are expected to drive the growth of the sexual health market.
Key features of the study
• This report provides in-depth analysis of the global sexual health market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2020-2027), considering 2018 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles leading players in the global sexual health market based on the following parameters – company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Inc., Eli Lilly & Company, Bayer AG, Vivus, Inc., Zydus Pharmaceuticals, IVFTECH APS, Merck & Co., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis International AG, Mylan Pharmaceuticals Inc., and AstraZeneca
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, government initiatives, technological upgradation, market expansion, and marketing tactics
• The global sexual health market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers in the sexual health market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
• Global Sexual Health Market, By Product Type
o Erectile Dysfunction Drugs
o Gender Dysphoria Drugs
o Hypoactive Sexual Desire Disorder Drugs
o Premature Ejaculation Drugs
o Others
• Global Sexual Health Market, By Gender
o Male
o Female
• Global Sexual Health Market, By Distribution Channel
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
• Global Sexual Health Market, By Region
o North America
U.S.
Canada
o Europe
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
o Asia Pacific
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Middle East
GCC
Israel
Rest of Middle East
o Africa
North Africa
Central Africa
South Africa
• Key Players
o Eli Lilly and Company
o Viatris
o Bayer AG
o Organon & Co.
o Gilead Sciences
o ViiV Healthcare
o Perrigo Company plc
o Reckitt
o Church & Dwight Co., Inc.
o CooperSurgical
o LifeStyles Healthcare
o Karex Berhad
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Product Type
Market Snippet, By Gender
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Technology Advancements
o Merger and Acquisition
o Regulatory Scenario
o PORTER’S Five Forces
o PEST Analysis
4. Global Sexual Health Market, By Product Type, 2021– 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Erectile Dysfunction Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Gender Dysphoria Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Hypoactive Sexual Desire Disorder Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Premature Ejaculation Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
5. Global Sexual Health Market, By Gender, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Male
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Female
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
6. Global Sexual Health Market, By Distribution Channel, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
7. Global Sexual Health Market, By Region, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, By Region, 2022 – 2033
Regional Trends
o North America
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Middle East
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Product Type, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Gender, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country/Region, 2021 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Teva Pharmaceutical Industries Ltd.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Meda Pharmaceuticals, Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Eli Lilly & Company
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Bayer AG
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Vivus, Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Zydus Pharmaceuticals
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
IVFTECH APS
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Merck & Co.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Pfizer Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Sun Pharmaceutical Industries Ltd
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Novartis International AG
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Mylan Pharmaceuticals Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
AstraZeneca
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們